Centre expands committee participation to usher in drugs pricing reforms
Department of pharmaceuticals broadens committee by including more industry groups to ensure pricing balance, availability of essential medicines and growth incentives.
DNA News Desk
0
5
Department of pharmaceuticals broadens committee by including more industry groups to ensure pricing balance, availability of essential medicines and growth incentives.
